MENU
+Compare
SXTP
Stock ticker: NASDAQ
AS OF
May 9 closing price
Price
$2.39
Change
+$0.13 (+5.75%)
Capitalization
3.52M

SXTP 60 Degrees Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases... Show more

SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SXTP with price predictions
May 09, 2025

SXTP's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for SXTP moved out of overbought territory on April 16, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 instances where the indicator moved out of the overbought zone. In of the 4 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SXTP as a result. In of 22 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SXTP turned negative on April 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SXTP broke above its upper Bollinger Band on April 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SXTP moved above its 50-day moving average on April 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SXTP crossed bullishly above the 50-day moving average on April 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTP advanced for three days, in of 75 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 37 cases where SXTP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.703). P/E Ratio (0.000) is within average values for comparable stocks, (64.016). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.990). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.788) is also within normal values, averaging (254.016).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SXTP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SXTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SXTP is expected to report earnings to fall 94.91% to -10 cents per share on May 14

60 Degrees Pharmaceuticals Inc. SXTP Stock Earnings Reports
Q1'25
Est.
$-0.11
Q4'24
Missed
by $1.98
Q3'24
Missed
by $0.71
Q2'24
Missed
by $4.03
Q1'24
Beat
by $0.21
The last earnings report on February 26 showed earnings per share of -216 cents, missing the estimate of -18 cents. With 39.03K shares outstanding, the current market capitalization sits at 3.52M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1025 Connecticut Avenue NW
Phone
+1 202 327-5422
Employees
3
Web
https://www.60degreespharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENVB1.280.01
+0.79%
Enveric Biosciences Inc
VIGL2.420.01
+0.41%
Vigil Neuroscience
BATRK40.50-0.01
-0.02%
Atlanta Braves Holdings
CINT6.16-0.05
-0.81%
CI&T
BBWI31.05-0.69
-2.17%
Bath & Body Works

SXTP and Stocks

Correlation & Price change

A.I.dvisor tells us that SXTP and CLDX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and CLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
+5.75%
CLDX - SXTP
23%
Poorly correlated
-6.10%
XFOR - SXTP
22%
Poorly correlated
+2.43%
ABSI - SXTP
22%
Poorly correlated
-1.79%
KROS - SXTP
21%
Poorly correlated
-2.64%
VIGL - SXTP
21%
Poorly correlated
+0.41%
More